Transcutaneous retrobulbar amphotericin B and exenteration in rhino-orbital cerebral mucor mycosis: Do we know it all yet?
Main Author: | Milind Naik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | TNOA Journal of Ophthalmic Science and Research |
Online Access: | http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2021;volume=59;issue=2;spage=131;epage=132;aulast=Naik |
Similar Items
-
Combination endoscopic surgical debridement and transcutaneous retrobulbar amphotericin B for acute rhino-orbital-cerebral aspergillosis
by: Kevin X. Zhang, et al.
Published: (2023-12-01) -
Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B
by: Mustafa Safi, et al.
Published: (2020-09-01) -
Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
by: Ramesh Murthy, et al.
Published: (2022-01-01) -
Spectral Domain Optical Coherence Tomography Findings in Vision-Threatening Rhino-Orbital Cerebral Mucor Mycosis—A Prospective Analysis
by: Ankur Singh, et al.
Published: (2022-12-01) -
Indications for exenteration and role of imaging in rhino-orbital-cerebral mucormycosis: An ophthalmologist's perspective
by: Jayashree Bakthavatchalam, et al.
Published: (2021-01-01)